Skip to main content

Wellness · Menopause

Menopause and HRT, a modern, evidence-first view.

HRT is safer, more effective and more available than 20-year-old headlines suggested. Here is how to have the right conversation, and what the current evidence supports.

Jump to how See red-flag signs
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Aligned with BMS and NICE

    Guidance drawn from the British Menopause Society, NICE NG23 and the Royal College of Obstetricians and Gynaecologists.

  • 03

    Evidence over headlines

    A plain, current view of HRT — not the 20-year-old story that still shapes the conversation.

Key facts

Menopause and HRT at a glance.

The essentials, in plain English — what menopause is, what modern HRT looks like, and what to bring to the conversation.

  • Definition

    Perimenopause is the run-up, menopause is 12 months after the last period, postmenopause is what follows.

  • Symptom breadth

    Symptoms range across around 35 domains — vasomotor, urogenital, cognitive, musculoskeletal and mood.

  • Modern HRT

    Transdermal estradiol with micronised progesterone has a favourable safety profile for most women.

  • BMS leadership

    The British Menopause Society is the leading UK specialist society and sets the standard for care.

  • Non-hormonal options

    SSRIs, CBT for menopause and gabapentin are evidence-based alternatives for those who cannot or prefer not to take HRT.

  • Individual decision

    Every decision is personal — bring a symptom list and your medical history to your consultation.

Why this guide matters

Old headlines, current evidence.

A generation of women were steered away from HRT by findings that have since been substantially revised. The three points below shape everything else on this page.

  • Modern HRT is different

    Transdermal estradiol with micronised progesterone has a very different profile from the older oral combined regimens.

  • Symptom breadth is under-recognised

    Around 35 symptom domains — joint pain, cognition, mood — not just hot flushes.

  • BMS-accredited care matters

    A clinician with current menopause training will give you a very different consultation from a rushed general appointment.

The evidence

A sensible order to work through the decision.

A pragmatic sequence — track symptoms, choose the right clinician, trial and tune.

  1. 01

    Prepare

    Track your symptoms

    A two-to-four week diary — hot flushes, sleep, mood, joints, cycle — gives the conversation something to work with.

  2. 02

    Prepare

    Book with a BMS-accredited clinician

    Accreditation signals proper training and current guidance — worth seeking out.

  3. 03

    Prepare

    Discuss benefits and risks

    Breast cancer, VTE and stroke risks — considered against your personal history rather than headlines.

  4. 04

    Trial

    Trial appropriate HRT

    Usually transdermal estradiol with micronised progesterone if the womb is intact — tailored to symptoms and risk.

  5. 05

    Trial

    Reassess at 3 months

    Most symptoms respond within twelve weeks — this is the point to judge fit.

  6. 06

    Tune

    Adjust dose or type

    Route, dose and preparation can all be tuned. Very few women get the perfect regimen first time.

  7. 07

    Tune

    Review annually

    A yearly review keeps the plan current — symptoms, risk profile and life stage all change.

Typical timeline: around 3 months from first appointment to a meaningful sense of what HRT can do for you.

Signs it affects you

Common signs, and one to escalate.

A quick self-check. Most of these are common and treatable — the final tile flags what warrants urgent gynae referral.

  • Hot flushes

    Sudden waves of heat, often with flushing and sweating — the classic vasomotor symptom.

  • Night sweats

    Wakeful, drenching sweats that break sleep — a leading cause of the fatigue women describe.

  • Mood changes

    Low mood, irritability, anxiety — real, common and often improved by HRT.

  • Libido changes

    Reduced desire — driven by hormones, sleep, mood and vaginal comfort together.

  • Joint pain

    Widespread aches and stiffness that appear or worsen around perimenopause — under-recognised.

  • Urogenital symptoms

    Dryness, discomfort, urinary urgency and recurrent UTIs — treatable with vaginal estrogen.

  • Cognitive fog

    Word-finding difficulty and poor concentration — often improves with HRT and sleep.

  • Red flag: postmenopausal bleeding

    Any bleeding after menopause needs urgent gynae referral — always.

How to do it

First-line options that actually help.

Eight options, evidence-based and widely available — often used together rather than in isolation.

  • Transdermal estradiol + micronised progesterone

    The modern first-line regimen for most women with a uterus — favourable VTE and cardiovascular profile.

  • Combined HRT (womb intact)

    Estrogen with a progestogen to protect the endometrium — sequential or continuous depending on stage.

  • Vaginal estrogen (topical)

    Low-dose topical estrogen for urogenital symptoms — safe for almost everyone, including many after breast cancer with specialist input.

  • Testosterone (specialist)

    Off-label in the UK for low libido unresponsive to HRT — specialist-led with monitoring.

  • SSRI/SNRI for vasomotor

    Non-hormonal option for hot flushes when HRT is unsuitable or declined.

  • CBT for menopause

    Structured CBT is evidence-based for vasomotor symptoms, sleep and mood.

  • Lifestyle (diet, exercise, sleep)

    Weight-bearing exercise, protein, sleep hygiene and reduced alcohol — real, additive gains.

  • Consultation with BMS-accredited menopause clinician

    The single most useful step for a tailored plan — worth prioritising over generic advice.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Every HRT decision is individual. A BMS-accredited menopause clinician can weigh benefits and risks against your own history.

  • British Menopause Society. Menopause guidance and consensus statements.

  • NICE. Menopause: diagnosis and management (NG23).

  • Royal College of Obstetricians and Gynaecologists. Menopause guidance.

  • The Menopause Charity. Patient-facing resources and clinician directory.

Red flags

When to seek help urgently.

These signs need prompt medical review or a change of provider. Please do not wait.

  • Postmenopausal bleeding

    Any bleeding after menopause needs urgent gynae referral — this is the single most important flag.

  • Breast lump

    Any new lump — see your GP without delay, whether on HRT or not.

  • Family history of breast/ovarian cancer

    A strong family history warrants a genetics review before starting HRT.

  • Personal VTE history

    Previous clot changes the calculation — transdermal routes and specialist input matter.

  • Uncontrolled hypertension

    Blood pressure should be reviewed and managed before or alongside HRT.

  • Migraine with aura

    Not an absolute barrier, but affects dose and route choice — flag it early.

  • Liver disease

    Active liver disease influences preparation and monitoring — declare it up front.

  • Diabetes with poor control

    Optimise glycaemic control alongside menopause care rather than in isolation.

  • Wellness clinics offering pellets without a safety net

    Unlicensed pellet HRT without proper follow-up is a red flag — stick with regulated care.

Making it stick

A tuned plan, reviewed each year.

Four principles to hold onto as you work through your menopause decision.

A quiet reminder

Every decision is individual.

Bring a symptom list to your consultation — it is the single most useful thing you can do to make the appointment work for you.

  1. 01 Evidence

    The story on HRT has moved on

    Modern regimens and better data have made HRT safer and more targeted than the 20-year-old headlines suggest.

  2. 02 Preparation

    Bring a symptom list

    A written list of symptoms, cycle and priorities makes for a much better consultation than trying to recall it all.

  3. 03 Fit

    Expect to tune the regimen

    Route, dose and preparation are all adjustable — most women need a change or two to land on the right fit.

  4. 04 Review

    Annual review keeps it right

    Symptoms and risk change over time — an annual review keeps the plan matched to where you are.

Frequently asked

Everything we get asked about menopause and HRT.

Quick answers on safety, timing, alternatives and when to see a specialist.

  • Is HRT safe?

    For most women in their 40s and 50s, modern transdermal estradiol with micronised progesterone has a favourable safety profile. Risks depend on personal history — a BMS-accredited clinician can walk through yours specifically.

  • What is the difference between perimenopause, menopause and postmenopause?

    Perimenopause is the transition, with fluctuating hormones and irregular cycles. Menopause is a single point — 12 months after the last period. Postmenopause is everything after that.

  • Does HRT cause breast cancer?

    The picture is more nuanced than the headlines. Estrogen-only HRT has little or no increase; combined HRT carries a small increased risk that must be weighed against symptom burden and other benefits. Discuss your own history with a specialist.

  • What if I cannot take HRT?

    Non-hormonal options include SSRIs or SNRIs for vasomotor symptoms, CBT for menopause, gabapentin, vaginal estrogen for local symptoms, and lifestyle change. A BMS-accredited clinician can build a plan without systemic HRT.

  • How long can I stay on HRT?

    There is no arbitrary stop date. The decision is reviewed annually against benefits, risks and symptoms — many women stay on HRT into their 60s and beyond with specialist review.

  • When should I see a specialist?

    If symptoms are affecting your life, if you have a complex history, or if a first HRT trial has not worked — a BMS-accredited menopause clinician is the right next step.

Related content

Keep reading.

WhatsApp Call us
Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

Confidential. We respond within one working day.